Home » News » Awards & Advancement » Galleon names Brookes senior VP

Galleon names Brookes senior VP

Thursday, December 1, 2011

Galleon Pharmaceuticals has named Lynne M. Brookes senior vice president and chief business officer.

Brookes joins Galleon from Cephalon where she held a variety of product management, marketing and business development positions and was most recently vice president of business development.

“Lynne is uniquely well-qualified to serve as our chief business officer because of her experience launching and managing very successful pharmaceutical products in markets that include many breathing-control-disorder patients. She provides a strong commercial perspective to complement our established drug-discovery and clinical-development teams,” said James C. Mannion, Ph.D., Galleon’s president, chief executive officer and founder.

Looking for more news, check out the new FREE CenterWatch Weekly!

The new FREE CenterWatch Weekly is your source of critical news, emerging trends, and business issues around everything in the rapidly changing clinical research marketplace. Check out our new CWWeekly page! Sign up today for your free email newsletter, update your bookmarks and check us out regularly! We look forward to bringing you the best news and information about clinical research in 2018!